http://www.kirkhamyoung.co.uk/news/rss/ Latest news about the Medical, Hospital and Scientific sectors. Disscussing Hospital sales jobs and scientific sales jobs. Fri, 18 May 2012 06:13:48 +0100 medical sales jobs through its purchase of a collagen manufacturing facility in Scotland to supply collagen products in the medical device markets.

The company has set up a new subsidiary, ABL, to supply the collagen products since making the £200,000 purchase. Angel is also reportedly in advanced negotiations for a long-term supply contract with a ‘sizeable’ client for materials supplied directly from ABL.

The company’s executive chairman, Paul Harper, said that the purchase of the manufacturing plant in Glasgow and the formation of ABL were important moves for the company and demonstrated their growing strength.

"The formation of ABL provides significant strategic advantages to the group, and the distinctive competencies offered will provide a one-stop shop for companies in the regenerative medicine space,” he explained.

A company spokesman added ABL would allow them to target the specific collagen products area, where opportunities can be quicker to realise than in Angel’s core business. He said, “ABL will make a positive contribution to the group's earnings within the short to medium term.”

The news of the purchase saw Angel’s share price rise 13.6 per cent to 0.2 pence.



]]> http://www.kirkhamyoung.co.uk/news/article/angel-biotechnology-making-strategic-growth-moves-183580.html http://www.kirkhamyoung.co.uk/news/article/angel-biotechnology-making-strategic-growth-moves-183580.html Fri, 11 May 2012 17:31:00 +0100
The figures, which are the product of research by analysts, Plimsoll, show that many British companies have succeeded in weathering the economic instability of recent years and managed to rebuild their profitability.

The leading analyst on the recent report, David Pattison, said that the industry has shown a marked turnaround from its position last year, when a similar piece of research showed that millions of pounds worth of profit was being wasted

“In our latest analysis, the number of companies making a loss has fallen from 202 to 174,” Pattison said. “It’s quite remarkable that so many companies have managed to rebuild their profitability during the worst trading conditions in recent memory.”

Some 98 of the 682 companies surveyed were placed in the ‘high profit’ category, averaging profits of around 24 per cent – three times higher than the overall profit margin of eight per cent. Pattison said that the ‘high profit’ companies demonstrated excellent management systems.

Pattison added that there was still work to be done, however, stating, “While there is good news elsewhere, it is worth remembering that there are still 174 companies making a loss, 82 of which are doing so for the second or even third year running.”



]]> http://www.kirkhamyoung.co.uk/news/article/scientific-equipment-companies-show-resurgent-strength-183487.html http://www.kirkhamyoung.co.uk/news/article/scientific-equipment-companies-show-resurgent-strength-183487.html Tue, 08 May 2012 16:26:00 +0100 medical sales jobs, it has been suggested.

The $3.7 billion acquisition deal is expected to help both firms to expand their presence in the life sciences industry.

Peter Abair, director of economic and global affairs at the Massachusetts Biotechnology Council, told the Boston Herald the deal may also be positive news for the medical sales jobs market. He is quoted as saying, "Hologic is becoming a bigger and bigger player. It speaks to the health of the company and the industry here."

Under the terms of the deal, Gen-Probe will become a subsidiary of Hologic, firm which specialises in medical devices related to women’s health, such as breast and cervical cancer treatments.

Media reports say that Gen-Probe recently got the go-ahead from the Food and Drug Administration to sell a test which can highlight whether men who have prostate cancer require a biopsy. The firm also sells products such as molecular diagnostic tests for sexually transmitted diseases and West Nile virus.

Rob Cascella, chief executive of Hologic, told the Financial Times, “With the addition of this product line and these products, we feel that we’re positioned to now have a high-growth molecular business and overall diagnostic business.”

He added, "This story is about the growth of two businesses on a faster trajectory.”



]]> http://www.kirkhamyoung.co.uk/news/article/genprobe-acquisition-could-boost-medical-sales-jobs-183446.html http://www.kirkhamyoung.co.uk/news/article/genprobe-acquisition-could-boost-medical-sales-jobs-183446.html Fri, 04 May 2012 15:48:00 +0100
Such confidence could provide a boost for medical sales jobs. The Global Medical Devices Survey 2012–2013: Market Trends, Marketing Spend and Sales Strategies in the Global Medical Devices Industry report, published by ICD Research, sheds light on planned media spend in the medical devices industry, as well as on how sales strategies and business plans are set to change in 2012–2013.

The research found that 54 per cent of those surveyed are “more optimistic” about increased profits for their business over the coming financial year compared to the last year. 27 per cent said they were "neutral", whilst just 18 per cent said they were “less optimistic” about revenue growth.

Optimism levels are slightly down since the 2010 and 2011 surveys, when 64 per cent and 61 per cent respectively said they were “more optimistic” about revenue growth. However, analysis from InfoGrok found that, “On a macro level, the results of 2010, 2011 and 2012 show little variation, suggesting that initiatives implemented in 2010 and 2011 have been sustained, and that the industry is progressing at a steady rate.”



]]> http://www.kirkhamyoung.co.uk/news/article/industry-optimism-could-boost-medical-sales-jobs-183357.html http://www.kirkhamyoung.co.uk/news/article/industry-optimism-could-boost-medical-sales-jobs-183357.html Tue, 01 May 2012 16:49:00 +0100 scientific sales jobs.

The Sand Hutton Applied Innovation Campus is to welcome its first tenants later this year, providing start-up and developing scientific businesses with the investment and research facilities to help them grow.

The site includes the York Science and Enterprise Centre, which was part funded by the European Regional Development Fund (ERDF).

The campus spokesman, Dr Patrick Bonnett, said that the labs and research amenities on the site would operate on a ‘plug and play’ principle, in that they could be changed to meet the needs of all the different companies as they develop.

He told the Yorkshire Post that it would become a “multi-occupancy site populated by a range of knowledge rich science and innovation based organisations”.

“Businesses are focused on the areas of food, environment and applied life sciences with the common theme being ‘translational’ research,” Dr Bonnett explained. “They are working across scientific disciplines to deliver practical applications that help people and society.”

As well as the labs and offices the site also offers a 250-seat conference hall, along with meeting rooms and a video conferencing facility.



]]> http://www.kirkhamyoung.co.uk/news/article/yorks-innovation-centre-offers-potential-for-scientific-sales-jobs-183304.html http://www.kirkhamyoung.co.uk/news/article/yorks-innovation-centre-offers-potential-for-scientific-sales-jobs-183304.html Fri, 27 Apr 2012 17:01:00 +0100
The company made a loss of €160 million in the fourth quarter of 2011, but has reported that it made a first-quarter net profit of €249 million in 2012, after sales climbed to some €5.608 billion.

The company’s chief executive, Frans van Houten, said that Philips' healthcare products have significantly increased their market share, showing that the company is “beating the competition”, even in a tough economic environment. He warned, however, that cut backs in government spending on healthcare across Europe meant that they remained cautious for the rest of 2012.

“We remain cautious about the remainder of 2012 given the uncertainties in Europe, particularly in the healthcare and construction markets, and the slowing growth rate in the global economy,” he explained.

The healthcare division of Philips produces a wide range of medical equipment used in hospitals, surgeries and domestic settings throughout Europe, ranging from home oxygen kits to hospital scanners.

Mr van Houten said that further restructuring of the company would be taking place in 2012, with particular focus put on the company’s corporate culture – which many people within the company consider overly consensus-driven and cautious.



]]> http://www.kirkhamyoung.co.uk/news/article/medical-sales-provide-philips-with-first-quarter-turnaround-183202.html http://www.kirkhamyoung.co.uk/news/article/medical-sales-provide-philips-with-first-quarter-turnaround-183202.html Tue, 24 Apr 2012 17:10:00 +0100
The hospital’s after-hours service, Hospital@Night, was the greatest beneficiary of the new system, which has seen nurses and doctors issued with Cisco Cius tablet devices which have been equipped with the specially devised NerveCentre app.

Patients’ details are entered onto a central PC system, which is accessible from the devices, and the Hospital@Night coordinator can the allocate tasks via the NerveCentre app. Junior doctors are allocated cases via this app and when they accept the assignment, the whole staff is able to see what the case is, who is doing it and when it is completed.

The director of ICT at Nottingham, Andre Fearn, said that the new system had brought an unprecedented level of efficiency and accountability to the hospital

“It was just lots of calling, paging and waiting [before],” he explained. “And assignments were logged on a dodgy Excel spreadsheet. The whole process was limited to one room, on one PC, and only one person could see it.”

He continued, “By using this app, so much clinical time has been put back into the organisation. We’ve got massive patient safety benefits but also it changes the way we work – there is more time to look after patients.”



]]> http://www.kirkhamyoung.co.uk/news/article/hospitals-logistics-benefit-from-mobile-admin-system-183138.html http://www.kirkhamyoung.co.uk/news/article/hospitals-logistics-benefit-from-mobile-admin-system-183138.html Fri, 20 Apr 2012 17:24:00 +0100 scientific sales jobs at medical testing kit maker, Omega Diagnostics, have contributed to an expected 40 per cent rise in the company’s full-year sales.

The company has benefited significantly from buying out German lab testing firm Allergopharma in November 2010, with Germany now Omega’s largest market.

In its pre-close trading update, the company, which is based in Alva in Scotland, has forecast that is revenues for the year to 31 March will be £11.1 million – up from £7.9 million for the previous 12 months.

Omega’s chief executive, Andrew Shepherd, said that underlying sales showed a year-on-year rise of 5 per cent.

“We are very pleased with the progress Omega has made and the overall business is performing strongly,” Shepherd said.

“We are also looking forward to significant opportunities presented by direct access into the Indian market, the launch of a range of allergy tests onto the automated IDS-iSYS platform and new prospects that exist that could transform the performance within our infectious disease portfolio.”

The revenue generated by Allergopharma is expected to have increased by more than 300 per cent on the previous year at £3.87 million, while sales of Omega's food intolerance testing kits are expected to have risen by 10 per cent to approximately £3.9 million.



]]> http://www.kirkhamyoung.co.uk/news/article/medical-sales-jobs-contribute-to-omega-success-183042.html http://www.kirkhamyoung.co.uk/news/article/medical-sales-jobs-contribute-to-omega-success-183042.html Tue, 17 Apr 2012 16:20:00 +0100 medical sales jobs.

The Japanese company this week announced that it was doubling the size of its estimated annual loss forecast to a record $6.4 billion, having lost major ground in its previously dominant television sector to companies including Apple and Samsung.

The company’s chief executive, Kazuo Hirai, told a packed news conference in Tokyo this week that the firm would be heeding “a multitude of investor voices calling for change” and that it would continue to enhance its long-held ethos of being an entrepreneurial company.

The company has been eyeing growth in the medical equipment market – particularly endoscopes. Sony has been linked as a potential partner to Olympus, which has a 70 per cent share of the global endoscope market, but needs to shore up its finances following a $1.7 billion accounting fraud.

Mr Hirai said that Sony is looking to establish total group sales of around $105 billion in 2014/15, with an operating margin of at least 5 per cent. He said that medical equipment sales would prove crucial to this.



]]> http://www.kirkhamyoung.co.uk/news/article/sony-turnaround-plan-could-create-medical-sales-jobs-182979.html http://www.kirkhamyoung.co.uk/news/article/sony-turnaround-plan-could-create-medical-sales-jobs-182979.html Fri, 13 Apr 2012 15:46:00 +0100
The framework – which has an estimated value of between £45 million and £125 million – is being established by the NHS Commercial Procurement Collaborative and NHS Shared Business Services.

A notice on the new initiative, issued by the Official Journal of the European Union, stated that the deal will cover the delivery of desktop computers and peripherals, laptops and touchscreen monitors, as well as medical equipment including x-ray workstations, mobile clinical assistant devices for use in “point of care and mobile environments”.

A wide range of some of the UK’s most eminent NHS trusts in England are expected to make use of the framework, including Alder Hey children's, Liverpool primary care, South West Yorkshire partnership and Yorkshire ambulance service.

The NHS Commercial Procurement Collaborative is the national procurement service for many public medical services across England. It sill set up the framework for an initial two-year period, but there will be the option to extend it for two further two-year terms.



]]> http://www.kirkhamyoung.co.uk/news/article/nhs-developing-new-procurement-framework-182883.html http://www.kirkhamyoung.co.uk/news/article/nhs-developing-new-procurement-framework-182883.html Tue, 10 Apr 2012 17:06:00 +0100